Sellas Cash And Short Term Investments vs Total Current Liabilities Analysis
SLS Stock | USD 1.13 0.04 3.42% |
Sellas Life financial indicator trend analysis is much more than just breaking down Sellas Life Sciences prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Sellas Life Sciences is a good investment. Please check the relationship between Sellas Life Cash And Short Term Investments and its Total Current Liabilities accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sellas Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Cash And Short Term Investments vs Total Current Liabilities
Cash And Short Term Investments vs Total Current Liabilities Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Sellas Life Sciences Cash And Short Term Investments account and Total Current Liabilities. At this time, the significance of the direction appears to have strong relationship.
The correlation between Sellas Life's Cash And Short Term Investments and Total Current Liabilities is 0.61. Overlapping area represents the amount of variation of Cash And Short Term Investments that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of Sellas Life Sciences, assuming nothing else is changed. The correlation between historical values of Sellas Life's Cash And Short Term Investments and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash And Short Term Investments of Sellas Life Sciences are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Cash And Short Term Investments i.e., Sellas Life's Cash And Short Term Investments and Total Current Liabilities go up and down completely randomly.
Correlation Coefficient | 0.61 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Cash And Short Term Investments
Short Term Investments is an account in the current assets section of Sellas Life Sciences balance sheet. This account contains Sellas Life investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Sellas Life Sciences fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.Total Current Liabilities
Total Current Liabilities is an item on Sellas Life balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Sellas Life Sciences are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most indicators from Sellas Life's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Sellas Life Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sellas Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. At this time, Sellas Life's Tax Provision is comparatively stable compared to the past year. Sales General And Administrative To Revenue is likely to gain to 11.89 in 2024, whereas Discontinued Operations is likely to drop (11.8 M) in 2024.
Sellas Life fundamental ratios Correlations
Click cells to compare fundamentals
Sellas Life Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Sellas Life fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 16.6M | 46.0M | 26.3M | 20.9M | 6.2M | 5.9M | |
Total Stockholder Equity | 6.1M | 28.0M | 20.3M | 4.9M | (8.0M) | (7.6M) | |
Net Debt | (7.1M) | (34.3M) | (20.5M) | (16.2M) | (1.6M) | (1.7M) | |
Cash | 7.3M | 35.3M | 21.4M | 17.1M | 2.5M | 2.4M | |
Cash And Short Term Investments | 7.3M | 35.3M | 21.4M | 17.1M | 2.5M | 2.4M | |
Common Stock Shares Outstanding | 2.6M | 8.0M | 15.5M | 19.4M | 27.8M | 29.2M | |
Liabilities And Stockholders Equity | 16.6M | 46.0M | 26.3M | 20.9M | 6.2M | 5.9M | |
Other Stockholder Equity | 107.2M | 145.9M | 158.9M | 184.8M | 209.3M | 145.3M | |
Total Current Assets | 8.2M | 36.9M | 23.0M | 17.8M | 3.2M | 3.0M | |
Other Current Liab | 1.2M | 1.7M | 2.4M | 11.4M | 7.7M | 6.4M | |
Total Current Liabilities | 5.3M | 12.3M | 5.0M | 15.5M | 13.7M | 19.4M | |
Retained Earnings | (101.1M) | (117.9M) | (138.6M) | (179.9M) | (217.2M) | (206.4M) | |
Accounts Payable | 3.9M | 4.7M | 2.1M | 3.4M | 5.6M | 3.3M | |
Non Current Assets Total | 8.4M | 9.1M | 3.2M | 3.2M | 3.0M | 2.9M | |
Non Currrent Assets Other | 536K | 614K | 594K | 399K | 275K | 261.3K | |
Other Current Assets | 84K | 1.6M | 1.7M | 631K | 642K | 609.9K | |
Total Liab | 10.5M | 18.1M | 5.9M | 16.1M | 14.2M | 25.9M | |
Non Current Liabilities Total | 5.2M | 5.8M | 946K | 577K | 460K | 437K | |
Net Tangible Assets | 4.2M | 20.3M | 18.4M | 2.9M | 3.4M | 3.2M | |
Retained Earnings Total Equity | (54.2M) | (81.9M) | (101.1M) | (117.9M) | (106.1M) | (111.4M) | |
Capital Surpluse | 56.3M | 87.1M | 107.2M | 145.9M | 131.3M | 135.0M | |
Non Current Liabilities Other | 5.3M | 5.0M | 4.6M | 296K | 266.4K | 253.1K | |
Other Assets | 536K | 7.2M | 594K | 399K | 1.0 | 0.95 | |
Deferred Long Term Liab | 1.7M | 357K | 262K | 239K | 215.1K | 204.3K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Sellas Stock Analysis
When running Sellas Life's price analysis, check to measure Sellas Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sellas Life is operating at the current time. Most of Sellas Life's value examination focuses on studying past and present price action to predict the probability of Sellas Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sellas Life's price. Additionally, you may evaluate how the addition of Sellas Life to your portfolios can decrease your overall portfolio volatility.